Detection of prostate cancer in symptomatic patients with prostate specific antigen between 4 and 10 ng/ml

被引:0
|
作者
Ravery, V
Schmid, HP
Billebaud, T
Toublanc, M
BocconGibod, L
Hermieu, JF
Delmas, V
BocconGibod, L
机构
[1] CHU BICHAT,SERV ANATOMOPATHOL,F-75877 PARIS 18,FRANCE
[2] HOP TROUSSEAU,SERV ANATOMOPATHOL,F-75571 PARIS,FRANCE
来源
PRESSE MEDICALE | 1996年 / 25卷 / 07期
关键词
MEN; CARCINOMA; AGE;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: Determine the incidence of prostate cancer in patients consulting for common miction disorders and serum prostatic specific antigen (PSA) between 4 and 10 ng/ml. Methods: A total of 153 patients consulted for miction disorders, In 107 of them, the digital examination was abnormal and PSA was between 3 and 10 ng/ml. Transrectal sonography and prostatic biopsies were performed in these 107 patients, We determined the number of cancers detected and assessed the contribution of PSA density (PSAD) to diagnosis, In patients undergoing radical prostatectomy, invasion of the capsule (C+) and positive exeresis section (M+) were recorded. Results: Cancer of the prostate was diagnosed in 29.4% of the patients on the basis of at least 1 of the 6 biopsies, This rate was 47.8% in patients with an abnormal and 21.5% with a normal digital examination, Radical prostatectomy was performed in 32 patients: 50% of them were C+ and 33% M+. Conclusion: Biopsy of the prostate is indicated in patients with an abnormal prostate at digital examination when PSA is between 4 and 10 ng/ml, When the prostate appears to be normal, PSAD may be helpful in determining when to perform a biopsy, Intermediary serum PSA levels do not guarantee favorable pathological characteristics.
引用
收藏
页码:272 / 276
页数:5
相关论文
共 50 条
  • [1] Multiparametric MRI for prostate cancer detection: Performance in patients with prostate-specific antigen values between 2.5 and 10 ng/mL
    Petrillo, Antonella
    Fusco, Roberta
    Setola, Sergio V.
    Ronza, Francesco M.
    Granata, Vincenza
    Petrillo, Mario
    Carone, Guglielmo
    Sansone, Mario
    Franco, Renato
    Fulciniti, Franco
    Perdona, Sisto
    JOURNAL OF MAGNETIC RESONANCE IMAGING, 2014, 39 (05) : 1206 - 1212
  • [2] Usefulness of Prostate Specific Antigen Density in Prostate Cancer Detection among Men with PSA of 4-10 ng/ml
    Agbo, C. A.
    Ramyil, V. M.
    Dakum, N. K.
    Shuaibu, S., I
    Akpayak, I. C.
    Ofoha, C. G.
    Onowa, V. E.
    Nabasu, L. E.
    Galam, Z. Z.
    ANNALS OF MEDICAL AND HEALTH SCIENCES RESEARCH, 2020, 10 (05) : 1138 - 1141
  • [3] Diagnostic value of microRNAs in prostate cancer patients with prostate specific antigen (PSA) levels between 2, and 10 ng/mL
    Akbayir, Serin
    Muslu, Necati
    Erden, Sema
    Bozlu, Murat
    TURKISH JOURNAL OF UROLOGY, 2016, 42 (04): : 247 - 255
  • [4] Is Prostate Specific Antigen Density more Important than in the Diagnosis of Prostate Cancer in Patients with a Total Prostate Specific Antigen Value <10 ng/mL?
    Coban, Soner
    Guzelsoy, Muhammet
    Turkoglu, Ali Riza
    Kurtoglu, Unal
    Unal, Dursun
    Akdur, Noyan Can
    Oner, Sedat
    Demirbas, Murat
    UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY, 2015, 14 (02): : 83 - 87
  • [5] VALUE OF PROSTATE SPECIFIC ANTIGEN (PSA) MASS RATIO IN THE DETECTION OF PROSTATE CANCER IN MEN WITH PSA ≤ 10 NG/ML
    Hong, Sung Kyu
    Oh, Jong Jin
    Lee, Sangchul
    Lee, Byung Ki
    Joo, Young Min
    Jeong, Chang Wook
    Jeong, Seong Jin
    Byun, Seok-Soo
    Lee, Sang Eun
    JOURNAL OF UROLOGY, 2012, 187 (04): : E895 - E895
  • [6] Serum pro prostate specific antigen improves cancer detection compared to free and complexed prostate specific antigen in men with prostate specific antigen 2 to 4 ng/ml
    Catalona, WJ
    Bartsch, G
    Rittenhouse, HG
    Evans, CL
    Linton, HJ
    Amirkhan, A
    Horninger, W
    Klocker, H
    Mikolajczyk, SD
    JOURNAL OF UROLOGY, 2003, 170 (06): : 2181 - 2185
  • [7] Comparison of percent free prostate specific antigen and prostate specific antigen density as methods to enhance prostate specific antigen specificity in early prostate cancer detection in men with normal rectal examination and prostate specific antigen between 4.1 and 10 ng/ml
    Morote, J
    Raventos, CX
    Lorente, JA
    LopezPacios, MA
    Encabo, G
    deTorres, I
    Andreu, J
    JOURNAL OF UROLOGY, 1997, 158 (02): : 502 - 504
  • [8] Nomogram for Prediction of Prostate Cancer with Serum Prostate Specific Antigen Less than 10 ng/mL
    Ahn, Jae Hyun
    Lee, Jeong Zoo
    Chung, Moon Kee
    Ha, Hong Koo
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2014, 29 (03) : 338 - 342
  • [9] SATURATION PROSTATE BIOPSY IS USEFUL AS INITIAL PROCEDURE TO DETECT PROSTATE CANCER IN PATIENTS WITH TOTAL PROSTATE SPECIFIC ANTIGEN (TPSA) LEVELS BETWEEN 4 TO 10 NG./ML
    Gavazzi, A.
    Cai, T.
    Mondaini, N.
    Melone, F.
    Farina, U.
    Bartoletti, R.
    EUROPEAN UROLOGY SUPPLEMENTS, 2010, 9 (02) : 53 - 53
  • [10] Prostate cancer diagnosis: should patients with prostate specific antigen &gt;10 ng/mL have stratified prostate biopsy protocols?
    Philip, Joe
    Manikandan, Ramaswamy
    Javle, Pradip
    Foster, Christopher S.
    CANCER DETECTION AND PREVENTION, 2009, 32 (04): : 314 - 318